Regulus Therapeutics Q4 Operating Expenses USD 13.746 Million
Reuters
03-14
March 13 (Reuters) - Regulus Therapeutics Inc:: *REGULUS THERAPEUTICS Q4 OPERATING EXPENSES USD 13.746 MILLION *REGULUS THERAPEUTICS Q4 INCOME FROM OPERATIONS USD -13.746 MILLION *REGULUS THERAPEUTICS Q4 BASIC EPS USD -0.2 *REGULUS THERAPEUTICS Q4 PRETAX PROFIT USD -12.791 MILLION *REGULUS THERAPEUTICS Q4 NET INCOME USD -12.791 MILLION *REGULUS THERAPEUTICS: CO EXPECTS ITS CASH RUNWAY TO EXTEND INTO EARLY 2026